Cite
HARVARD Citation
Magnè, F. et al. (2023). Anti-SARS-CoV-2 monoclonal antibodies for the treatment of active COVID-19 in multiple sclerosis: An observational study. Multiple sclerosis. pp. 481-482. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Magnè, F. et al. (2023). Anti-SARS-CoV-2 monoclonal antibodies for the treatment of active COVID-19 in multiple sclerosis: An observational study. Multiple sclerosis. pp. 481-482. [Online].